Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5917774 | 0.98 | KDM4E (0.33) | KDM4ETSHRTDP1PGK1PGK2 | |
| Alcohol SCHEMBL11401577 | 0.90 | FDPS (0.33) | PGK1PGK2LMNA | |
| SCHEMBL6518484 | 0.87 | PGD (0.34) | TSHR | |
| SCHEMBL5904251 | 0.85 | FDPS (0.32) | — | |
| Pentachlorophenol SCHEMBL7643300 | 0.82 | TSHR (0.32) | TSHRLMNA | |
| Cyclohexylamine SCHEMBL16059711 | 0.82 | MMP8 (0.40) | — | |
| SCHEMBL458686 | 0.76 | PGK1 (0.33) | KDM4ETSHRTDP1PGK1PGK2 | |
| SCHEMBL2202444 | 0.76 | CPT2 (0.40) | PGK1PGK2LMNA | |
| SCHEMBL8842579 | 0.71 | LMNA (0.36) | TSHRLMNA | |
| SCHEMBL19043014 | 0.71 | FOLH1 (0.36) | TSHRTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3823 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069577-A1 | METHODS FOR IMPROVING EXERCISE PERFORMANCE AND ENDURANCE THEREOF | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2026-03-12 | — | — | US | claimed |
| US-20250387386-A1 | METHODS OF USING PYRUVATE KINASE ACTIVATORS | AGIOS PHARMACEUTICALS INC (US) | 2025-12-25 | — | — | US | claimed |
| US-12496294-B2 | Methods for improving exercise performance and endurance thereof | NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| US-20250332161-A1 | PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY | AGIOS PHARMACEUTICALS INC (US) | 2025-10-30 | — | — | US | claimed |
| EP-4623991-A2 | METHODS FOR THE STORAGE OF WHOLE BLOOD, AND COMPOSITIONS THEREOF | Hemanext Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| EP-4591711-A1 | COMPOSITIONS FOR BLOOD STORAGE AND TRANSFUSIONS | Albert Einstein College of Medicine (US) | 2025-07-30 | — | — | EP | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| US-20250177440-A1 | Methods for Managing Adverse Events in Patient Populations Requiring Transfusion | HEMANEXT INC. (US) | 2025-06-05 | — | — | US | claimed |
| US-20250064721-A1 | TRANSDERMAL DELIVERY FORMULATIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2025-02-27 | — | — | US | claimed |
| US-12151019-B2 | Compositions for blood storage and transfusions | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2024-11-26 | — | — | US | claimed |
| EP-0146338-A2 | A blood accelerator 2, 3-diphosphoglyceric acid | SHIRATORI PHARMACEUTICAL CO. LTD. (JP) | 1985-06-26 | — | — | EP | claimed |
| EP-0046176-B1 | ENZYMATIC CONVERSION OF RED CELLS FOR TRANSFUSION | New York Blood Center, Inc. (US) | 1985-04-24 | — | — | EP | claimed |
| EP-0077515-B1 | METHOD AND COMPOSITION FOR DETERMINING GLYCOSYLATED HEMOGLOBIN | Roche Diagnostics GmbH (DE) | 1985-03-20 | — | — | EP | claimed |
| EP-0132655-A2 | Enzymatic conversion of certain sub-type A and AB erythrocytes | New York Blood Center, Inc. (US) | 1985-02-13 | — | — | EP | claimed |
| US-4473496-A | Intramolecularly crosslinked hemoglobin | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-09-25 | — | — | US | claimed |
| US-4438204-A | Determination of glycosilated hemoglobin | BOEHRINGER MANNHEIM GMBH (DE) | 1984-03-20 | — | — | US | claimed |
| US-4427777-A | Enzymatic conversion of red cells for transfusion | NEW YORK BLOOD CENTER, INC. (US) | 1984-01-24 | — | — | US | claimed |
| EP-0077515-A2 | Method and composition for determining glycosylated hemoglobin | Roche Diagnostics GmbH (DE) | 1983-04-27 | — | — | EP | claimed |
| EP-0046176-A2 | Enzymatic conversion of red cells for transfusion | New York Blood Center, Inc. (US) | 1982-02-24 | — | — | EP | claimed |
| US-4216211-A | INCREASES LEVEL OF 2,3-DIPHOSPHOGLYCERATES IN THE BLOOD | THE PROCTER & GAMBLE COMPANY (US) | 1980-08-05 | — | — | US | claimed |